Identification of Serum Biomarkers for Biliary Tract Cancers by a Proteomic Approach Based on Time-of-Flight Mass Spectrometry
Open Access
Abstract
Biliary tract cancers (BTCs) are lethal malignancies currently lacking satisfactory methods for early detection and accurate diagnosis. Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) is a promising diagnostic tool for this disease. In this pilot study, sera samples from 50 BTCs and 30 cholelithiasis patients as well as 30 healthy subjects from a population-based case-control study were randomly grouped into training set (30 BTCs, 20 cholelithiasis and 20 controls), duplicate of training set, and blind set (20 BTCs, 10 cholelithiasis and 10 controls); all sets were analyzed on Immobilized Metal Affinity Capture ProteinChips via SELDI-TOF-MS. A decision tree classifier was built using the training set and applied to all test sets. The classification tree constructed with the 3,400, 4,502, 5,680, 7,598, and 11,242 mass-to-charge ratio (m/z) protein peaks had a sensitivity of 96.7% and a specificity of 85.0% when comparing BTCs with non-cancers. When applied to the duplicate set, sensitivity was 66.7% and specificity was 70.0%, while in the blind set, sensitivity was 95.0% and specificity was 75.0%. Positive predictive values of the training, duplicate, and blind sets were 82.9%, 62.5% and 79.2%, respectively. The agreement of the training and duplicate sets was 71.4% (Kappa = 0.43, u = 3.98, P < 0.01). The coefficient of variations based on 10 replicates of one sample for the five differential peaks were 15.8–68.8% for intensity and 0–0.05% for m/z. These pilot results suggest that serum protein profiling by SELDI-TOF-MS may be a promising approach for identifying BTCs but low assay reproducibility may limit its application in clinical practice.Keywords
This publication has 27 references indexed in Scilit:
- Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis†Hepatology, 2008
- Screening serum hepatocellular carcinoma-associated proteins by SELDI-based protein spectrum analysisWorld Journal of Gastroenterology, 2008
- [A survey on the diagnosis and treatment of biliary tract cancers in Shanghai].2005
- Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors.2002
- Cancer incidence trends in urban Shanghai, 1972-1994: An updateInternational Journal of Cancer, 1999
- Epidemiology of gallbladder cancer.1999
- Diagnostic and prognostic values of CA 19-9 and CEA in periampullary cancers11No competing interests declared.Journal of the American College of Surgeons, 1999
- The National Cancer Data Base report on carcinoma of the gallbladder, 1989-1995Cancer, 1998
- Liver, gallbladder, extrahepatic bile ducts, and pancreasCancer, 1995
- Serum CEA and CA 19‐9: Potential future diagnostic or screening tests for gallbladder cancer?International Journal of Cancer, 1990